22 research outputs found

    Donoso Cort茅s profeta ignorado. Un an谩lisis de la secularizaci贸n y la religi贸n de la humanidad

    Get PDF
    Introducci贸n   El siguiente trabajo pretende desarrollar la tesis de Donoso Cort茅s sobre la secularizaci贸n. Para el pensador espa帽ol, la descristianizaci贸n del mundo conlleva a la desintegraci贸n del orden natural y su sustituci贸n por un orden artificial pol铆tico que se sacraliza. La secularizaci贸n para Donoso es la sacralizaci贸n de instituciones como el Estado o entes abstractos como el de humanidad. Adem谩s, subraya que el orden artificial que surgen como sustituci贸n est谩n compuestos de diversos mitos como el del progreso indefinido de la humanidad, negando as铆 el car谩cter puramente racional de la modernidad, y que, llevan a la humanidad a senderos de aniquilaci贸

    Augusto del Noce: El problema de la sociedad opulenta como nuevo totalitarismo de masas y la recuperaci贸n del concepto de tradici贸n en el pensamiento de Agust铆n de Hipona como respuesta a 茅sta. : Breve perspectiva en el pensamiento de Augusto Del Noce

    No full text
    El presente ensayo reflexiona en torno a la figura de un pensador italiano Augusto Del Noce y su lectura de lo que el llamo como 鈥淪ociedad Opulenta鈥. Esto con el motivo de analizar sus consecuencias y el problema en torno a los totalitarismos que acontecieron durante el siglo XX y el actual que sigue haciendo estragos en el esp铆ritu humano. El nuevo totalitarismo es sutil, no construye ni gulags ni campos de exterminio, pero opera de una forma silenciosa en el esp铆ritu humano: 驴C贸mo opera este nuevo totalitarismo? En recortar el esp铆ritu humano a mero cuerpo operativo que se ajusta a un sistema instrumental en la sociedad. La sociedad actual que es totalmente instrumental se adjudica a s铆 misma como un mundo donde las preguntas metaf铆sicas, filos贸ficas, teol贸gicas no solo son irracionales, sino que carecen de sentido hacerlas, ya que no contestan nada para el hombre de dicha sociedad

    Nolanville Comprehensive Plan 2021-2041

    Get PDF
    Nearly five years after the completion of the 2015 Comprehensive Plan, TxTC partnered with the City of Nolanville again in 2019 with the ENDEAVR project. ENDEAVR (Envisioning the Neo-traditional Development by Embracing the Autonomous Vehicles Realm)鈥 is an ambitious project to re-envision 鈥漵mart鈥 city solutions in small towns with students from a wide range of university degree programs in urban planning, landscape architecture, visualization, computer science, and civil, electrical and mechanical engineering. ENDEAVR launched in 2018 with a $300,000 grant from the Keck Foundation, which supports projects that promote inventive educational approaches. The City of Nolanville sought to explore 鈥渟mart鈥 city solutions to make efficient and prudent improvements to traffic flow, public safety, optimize utility systems, high-bandwidth digital networks, and foster autonomous vehicles. Additionally, TxTC included these 鈥渟mart鈥 city solutions to update its 2015 comprehensive plan. The new 2020 comprehensive plan embeds 鈥渟mart鈥 city solutions into its priorities and capital improvement projects to foster diversity and continue to make Nolanville 鈥淎 Great Place to Live鈥

    Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

    No full text
    BACKGROUND: Cardiovascular (CV) disease is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Furthermore, patients with T2DM and acute coronary syndrome (ACS) have a particularly high risk of CV events. The glucagon-like peptide 1 receptor agonist, lixisenatide, improves glycemia, but its effects on CV events have not been thoroughly evaluated. METHODS: ELIXA (www.clinicaltrials.gov no. NCT01147250) is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study of lixisenatide in patients with T2DM and a recent ACS event. The primary aim is to evaluate the effects of lixisenatide on CV morbidity and mortality in a population at high CV risk. The primary efficacy end point is a composite of time to CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. Data are systematically collected for safety outcomes, including hypoglycemia, pancreatitis, and malignancy. RESULTS: Enrollment began in July 2010 and ended in August 2013; 6,068 patients from 49 countries were randomized. Of these, 69% are men and 75% are white; at baseline, the mean 卤 SD age was 60.3 卤 9.7 years, body mass index was 30.2 卤 5.7 kg/m(2), and duration of T2DM was 9.3 卤 8.2 years. The qualifying ACS was a myocardial infarction in 83% and unstable angina in 17%. The study will continue until the positive adjudication of the protocol-specified number of primary CV events. CONCLUSION: ELIXA will be the first trial to report the safety and efficacy of a glucagon-like peptide 1 receptor agonist in people with T2DM and high CV event risk

    Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    No full text

    Alirocumab and cardiovascular outcomes after acute coronary syndrome

    No full text
    BACKGROUN

    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial